WIPIT provided legal counsel to HealthTech company CollimateHealth on its successful €6m seed funding round. CollimateHealth is developing the first clinically scalable microbeam therapy with the potential to fundamentally advance radiation therapy in oncology. The company will use the new capital to accelerate the development of its first clinical prototype and bring the technology a decisive step closer to patient application. We are pleased to have supported the CollimateHealth founding team in this important milestone and thank them for the trusting and constructive collaboration. We also extend our thanks to all participating investors for the professional and collaborative process. The WIPIT team was led by Benedikt Mahr and also included Christian Deutscher (both Munich). We congratulate CollimateHealth and all parties involved on the successful closing of the funding round and wish them continued success in implementing this innovative technology.

‍